pentoxifylline has been researched along with Dermatitis, Atopic in 1 studies
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, SK | 1 |
| Dimri, U | 1 |
| Saxena, SK | 1 |
| Jadhav, RK | 1 |
1 other study available for pentoxifylline and Dermatitis, Atopic
| Article | Year |
|---|---|
Therapeutic management of canine atopic dermatitis by combination of pentoxifylline and PUFAs.
Topics: Animals; Dermatitis, Atopic; Dog Diseases; Dogs; Drug Therapy, Combination; Fatty Acids, Unsaturated | 2010 |